---
title: "Oxalate transport in cultured porcine renal epithelial cells | Sutter Health"
description: "Oxalate transport in cultured porcine renal epithelial cells."
url: "https://www.sutterhealth.org/research/publications/oxalate-transport-in-cultured-porcine-renal-epithe-1055312722"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Research publications](https://www.sutterhealth.org/research/publications) /
4.  Oxalate transport in cultured porcine renal epithelial cells

# Oxalate transport in cultured porcine renal epithelial cells.

T R Wandzilak 1, L Calo, S D'Andre, A Borsatti, & H E Williams

_T R Wandzilak 1_

_L Calo_

_S D'Andre_

_A Borsatti_

_H E Williams_

1992-07-20

## Abstract

Oxalate-containing kidney stones are the most common type (75%) of renal stones. In order to control oxalate excretion in the urine, a basic understanding of the cellular transport of oxalate is imperative. We have utilized the technique of continuous cell culture to establish and characterize a model system to study renal epithelial cell (LLCPK1) oxalate transport. Our data demonstrate that oxalate uptake in these cells is dependent on time, concentration and energy. The Km for oxalate uptake was 200 microM. Oxalate uptake was decreased at lower temperatures and elevated in an acidic extracellular environment. Both anion exchange inhibitors DIDS and SITS inhibited oxalate uptake. Sulfate, chloride, and bicarbonate decreased oxalate uptake, as did the diuretics bumetanide and furosemide. There was no evidence for the co-transport of oxalate with sodium. Our data show that monolayers of cultured kidney epithelial cells are a valuable model system for study of the basic cellular mechanisms of oxalate transport.

[PubMed abstract](https://pubmed.ncbi.nlm.nih.gov/1455566/)

## Research topics

-   [All Cancer](https://www.sutterhealth.org/research-search-results?query=%22%5C%22All+Cancer%5C%22%22)

## Related publications

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

-   Publication
    
    ### [Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California](https://www.sutterhealth.org/research/publications/breast-cancer-subtypes-as-defined-by-the-estrogen-1055312635)
    
    1999-2004. Breast J. November/December 2009;15(6):593-602.
    
    Breast Journal
    
    2009 Dec 20
    
-   Publication
    
    ### [Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial](https://www.sutterhealth.org/research/publications/sociopsychological-tailoring-to-address-colorectal-1055312656)
    
    Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial. Jerant A1, Kravitz RL, Sohler N, Fiscella K, Romero RL, Parnes B, Tancredi DJ, Aguilar-Gaxiola S, Slee C, Dvorak S, Turner C, Hudnut A, Prieto F, Franks P.
    
    Ann Fam Med. 2014 May-Jun;12(3):204-14. doi: 10.1370/afm.1623. Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial.
    
    2014 May 30
    
-   Publication
    
    ### [Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers](https://www.sutterhealth.org/research/publications/breast-cancer-survival-defined-by-the-er-pr-her2-1055312621)
    
    Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. Parise CA, Caggiano V. J Cancer Epidemiol. 2014;2014:469251. doi: 10.1155/2014/469251. Epub 2014 May 26
    
    Breast Journal
    
    2014 May 26
    
-   Publication
    
    ### [Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California.](https://www.sutterhealth.org/research/publications/disparities-in-receipt-of-adjuvant-radiation-1055312768)
    
    2012 May 1;118(9):2516-24. doi: 10.1002/cncr.26542. Epub 2011 Sep 14. Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California.
    
    Cancer
    
    2011 Sep 14
    
-   Publication
    
    ### [Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.](https://www.sutterhealth.org/research/publications/raloxifene-is-associated-with-less-side-effects-th-1055312770)
    
    J Womens Health Gend Based Med. 2002 Apr;11(3):291-301.
    
    J Womens Health Gend Based Med. 2002 Apr;11(3):291-301.
    
    2002 Apr 20
    

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/publications/oxalate-transport-in-cultured-porcine-renal-epithe-1055312722#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research publications","item":"https://www.sutterhealth.org/research/publications"},{"@type":"ListItem","position":4,"name":"Oxalate transport in cultured porcine renal epithelial cells"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalScholarlyArticle","@id":"https://www.sutterhealth.org/research/publications/oxalate-transport-in-cultured-porcine-renal-epithe-1055312722#medicalscholarlyarticle","name":"Oxalate transport in cultured porcine renal epithelial cells.","headline":"Oxalate transport in cultured porcine renal epithelial cells","abstract":"Oxalate-containing kidney stones are the most common type (75%) of renal stones. In order to control oxalate excretion in the urine, a basic understanding of the cellular transport of oxalate is imperative. We have utilized the technique of continuous cell culture to establish and characterize a model system to study renal epithelial cell (LLCPK1) oxalate transport. Our data demonstrate that oxalate uptake in these cells is dependent on time, concentration and energy. The Km for oxalate uptake was 200 microM. Oxalate uptake was decreased at lower temperatures and elevated in an acidic extracellular environment. Both anion exchange inhibitors DIDS and SITS inhibited oxalate uptake. Sulfate, chloride, and bicarbonate decreased oxalate uptake, as did the diuretics bumetanide and furosemide. There was no evidence for the co-transport of oxalate with sodium. Our data show that monolayers of cultured kidney epithelial cells are a valuable model system for study of the basic cellular mechanisms of oxalate transport.","description":"Oxalate transport in cultured porcine renal epithelial cells.","keywords":["All Cancer"],"datePublished":"1992-07-20","url":"https://www.sutterhealth.org/research/publications/oxalate-transport-in-cultured-porcine-renal-epithe-1055312722","inLanguage":"en-US","identifier":[{"@type":"PropertyValue","propertyID":"PMID","value":"1455566"}],"sameAs":["https://pubmed.ncbi.nlm.nih.gov/1455566/"],"isPartOf":{"@type":"Periodical","name":"T R Wandzilak"},"sourceOrganization":{"@type":"MedicalOrganization","name":"Sutter Institute for Medical Research"},"about":[{"@type":"DefinedTerm","name":"All Cancer","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22All+Cancer%22%5D%7D%5D&verticalKey=research_publication"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.sutterhealth.org/research/publications/oxalate-transport-in-cultured-porcine-renal-epithe-1055312722","breadcrumb":{"@id":"https://www.sutterhealth.org/research/publications/oxalate-transport-in-cultured-porcine-renal-epithe-1055312722#breadcrumblist"}}}
```
